We are live on ! Find out more
TS

Thomas Steyer Farallon Capital Management

AUM $21.7B
1-Year Est. Return 79.24%
 

Thomas Steyer founded Farallon Capital Management, a pioneering multi-strategy firm spanning credit, equities, real estate, and event-driven investing. Farallon became known for rigorous research and opportunistic capital allocation across cycles. Although Steyer later focused on public advocacy, the Farallon name remains important in hedge fund history and ongoing 13F tracking.

This Fund
S&P 500
This Quarter Est. Return
+10.26%
1 Year Est. Return
+79.24%
3 Year Est. Return
+204.51%
5 Year Est. Return
+270.91%
10 Year Est. Return
+1,884.18%
AUM
$9.11B
AUM Growth
+$430M
Cap. Flow
-$417M
Cap. Flow %
-4.58%
Top 10 Hldgs %
48.86%
Holding
90
New
18
Increased
24
Reduced
16
Closed
18

Top Buys

Rank Stock Value
1
YHOO
Yahoo Inc
YHOO
+$394M
2
META icon
Meta Platforms (Facebook)
META
+$345M
3
TWX
Time Warner Inc
TWX
+$345M
4
PLYA
Playa Hotels & Resorts
PLYA
+$311M
5
WAB icon
Wabtec
WAB
+$261M

Top Sells

Rank Stock Value
1
STJ
St Jude Medical
STJ
+$712M
2
CPAY icon
Corpay
CPAY
+$189M
3
CHTR icon
Charter Communications
CHTR
+$130M
4
BKNG icon
Booking.com
BKNG
+$110M
5
SSNC icon
SS&C Technologies
SSNC
+$109M

Sector Composition

Rank Sector Weight
1 Communication Services 22.15%
2 Technology 15.42%
3 Healthcare 15.15%
4 Industrials 8.86%
5 Consumer Staples 7.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AKAO
51
DELISTED
Achaogen Inc
AKAO
$20.6M 0.23%
817,500
+467,500
+134% +$9.6M
GRFS
52
Grifois
GRFS
$5.44B
$20.4M 0.22%
1,079,874
– –
KYNB
53
Kyntra Bio
KYNB
$30.4M
$16.8M 0.18%
27,280
-4,000
-13% -$2.44M
RYAAY icon
54
Ryanair
RYAAY
$28.9B
$15.2M 0.17%
+459,288
New +$15.2M
PTLA
55
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$15.1M 0.17%
385,000
+285,000
+285% +$9.08M
CLUB
56
DELISTED
Town Sports International Holdings, Inc.
CLUB
$14.4M 0.16%
4,060,082
– –
LKFT
57
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.89B
$10.3M 0.11%
120,000
+29,045
+32% +$2.09M
NVET
58
DELISTED
Nexvet Biopharma plc Ordinary Shares
NVET
$10.3M 0.11%
2,648,696
– –
STML
59
DELISTED
Stemline Therapeutics, Inc.
STML
$9.98M 0.11%
1,167,500
+910,000
+353% +$8.29M
LJPC
60
DELISTED
La Jolla Pharmaceutical Company
LJPC
$7.69M 0.08%
+257,500
New +$6.57M
PCO
61
DELISTED
Pendrell Corporation - Class A
PCO
$5.34M 0.06%
8,211
– –
CLVS
62
DELISTED
Clovis Oncology, Inc.
CLVS
$5.09M 0.06%
+80,000
New +$4.86M
KATE
63
DELISTED
Kate Spade & Company
KATE
$4.88M 0.05%
+210,000
New +$4.39M
AMRN
64
Amarin Corp
AMRN
$298M
$4.78M 0.05%
74,750
-30,500
-29% -$1.94M
ALR
65
CALL
DELISTED
Alere Inc
ALR
$3.26M 0.04%
+82,000
New +$3.2M
ACRS icon
66
Aclaris Therapeutics
ACRS
$944M
$3.19M 0.04%
+106,894
New +$3.08M
GCVRZ
67
DELISTED
Sanofi Contingent Value Rights
GCVRZ
$3.07M 0.03%
6,827,805
– –
MITL
68
DELISTED
Mitel Networks Corporation
MITL
$2.68M 0.03%
386,267
– –
ABBV icon
69
AbbVie
ABBV
$468B
– –
-160,000
Closed -$10M
BCE icon
70
BCE
BCE
$22.1B
– –
-133,650
Closed -$5.78M
GILD icon
71
Gilead Sciences
GILD
$181B
– –
-135,000
Closed -$9.67M
HPP
72
Hudson Pacific Properties
HPP
$787M
– –
-165,703
Closed -$40.3M
ILMN icon
73
Illumina
ILMN
$33.1B
– –
-19,532
Closed -$2.43M
LILA icon
74
Liberty Latin America Class A
LILA
$1.66B
– –
-1,848,120
Closed -$26M
SPY icon
75
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$809B
– –
-7,080,000
Closed -$1.58B
1 2
3
4

Similar funds

BG
Bahl & Gaynor Cincinnati, Ohio $21.7B AUM 30.58% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.7B AUM 77.3% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $21.7B AUM 41.93% 1-Year Est. Return
SA
Sanctuary Advisors Indianapolis, Indiana $21.6B AUM 28.31% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $21.5B AUM 23.65% 1-Year Est. Return
CHP
Castle Hook Partners New York $21.8B AUM 215.45% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Thomas Steyer's Q1 2017 Portfolio in Review

As of Q1 2017, Thomas Steyer held 90 positions worth $9.11B, up 5% from $8.68B the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Thomas Steyer withdrew a net $417M in Q1 2017, closing 18 positions and reducing 16 holdings. Its most notable exit was St Jude Medical, an estimated $712M position sold in full.

By sector, the portfolio is most concentrated in Communication Services at 22% of assets, up from 14% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Thomas Steyer opened a new position in Meta Platforms (Facebook) worth $367M.

  • Thomas Steyer's largest Q1 2017 buy was Meta Platforms (Facebook): 2,583,043 shares worth $367M.
  • Thomas Steyer added most to Yahoo Inc in Q1 2017, an estimated $394M increase.
  • Thomas Steyer's biggest Q1 2017 reduction was Corpay, cutting an estimated $189M.
  • Thomas Steyer fully exited St Jude Medical in Q1 2017, selling an estimated $712M.
  • Thomas Steyer's ten largest holdings make up 49% of its $9.11B portfolio in Q1 2017.
  • Thomas Steyer opened 18 new positions and closed 18 in Q1 2017.
  • Thomas Steyer's portfolio value rose 5% quarter-over-quarter to $9.11B.

Based on Farallon Capital Management's 13F filing for Q1 2017, filed 15 May 2017.